Position in NEO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,605,483
+$623,446 QoQ
Shares Held
110,040
-16.9% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#74
of 266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PERKINS CAPITAL MANAGEMENT INC holds $26,693,573 across 9 Diagnostics & Research names. NEO ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
40,605 | $11,022,227 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
9,700 | $5,106,468 | |
| 3 | VCYT |
Veracyte, Inc.
|
59,958 | $3,521,333 | |
| 4 | PSNL |
Personalis, Inc.
|
239,000 | $3,202,600 | |
| 5 | NEO |
Neogenomics Inc
This page
|
110,040 | $1,605,483 | |
| 6 | BDSX |
Biodesix Inc
|
44,618 | $1,006,135 | |
| 7 | MDXH |
MDxHealth SA
|
1,411,891 | $580,287 | |
| 8 | CSTL |
Castle Biosciences Inc
|
16,140 | $384,939 |
All Filings in NEO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,605,483 | 110,040 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $982,037 | 132,350 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,668,156 | 141,850 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,056,482 | 136,850 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,227,714 | 167,950 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,703,929 | 179,550 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,949,096 | 178,950 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,666,800 | 180,800 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,597,851 | 187,300 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,037,104 | 193,200 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,125,976 | 193,200 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $2,385,585 | 193,950 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $3,157,755 | 196,500 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $3,429,770 | 197,000 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,826,748 | 197,700 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,683,685 | 195,550 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,650,782 | 202,550 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,853,482 | 152,550 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $5,307,366 | 155,550 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $7,609,860 | 157,750 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $7,150,411 | 158,300 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $7,755,384 | 160,800 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $9,758,500 | 181,250 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $7,360,477 | 199,525 | Shares | Sole | 2020-10-28 | |
| 2020-03-31 | $6,484,208 | 234,850 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||